发明名称 PHARMACEUTICAL COMPOSITION HAVING SYNERGISTIC ACTION OF DIRECT CATALASE INHIBITORS AND MODULATORS OF NO METABOLISM OR OF EXTRACELLULAR SUPEROXIDE ANION PRODUCTION WHICH LEAD TO CATALASE DESTRUCTION
摘要 Composition comprises at least one active ingredient, which brings a singlet oxygen-independent direct catalase inactivation, where the composition further comprises at least one active ingredient, which leads to inactivation of catalase as a result of modulation of the nitrogen oxide or superoxide anion metabolism of the cells and subsequent singlet oxygen formation. ACTIVITY : Cytostatic. MECHANISM OF ACTION : None given.
申请公布号 EP2863907(A1) 申请公布日期 2015.04.29
申请号 EP20130729758 申请日期 2013.06.20
申请人 UNIVERSITÄTSKLINIKUM FREIBURG 发明人 BAUER, GEORG
分类号 A61K31/35;A61K31/055;A61K31/19;A61K31/198;A61K31/337;A61K31/352;A61K31/375;A61K31/454;A61K31/55;A61K39/395;A61P9/00;A61P9/04;A61P9/12;A61P35/00 主分类号 A61K31/35
代理机构 代理人
主权项
地址